Attend PACK EXPO – this year’s can’t-miss event in Chicago, Oct 23-26.
Discover solutions from 2,000+ exhibitors to advance your operations and network with colleagues at PACK EXPO International.
REGISTER TODAY

Schott Inaugurates Plant for Prefillable Polymer Syringes

The new manufacturing facility in Müllheim, Germany, includes a R&D center to drive rapid prototyping of new polymer syringe solutions, as well as a logistics and an integrated administrative area.

Schott Muellheim Factory

The international technology group Schott is celebrating the inauguration of its new Müllheim, Germany, manufacturing facility for prefillable syringes made of high-end polymer. “Today’s opening marks a big step in our strategic business expansion,” says Andreas Reisse, executive vice president of Schott’s pharma business unit. “The new facility in Müllheim aims to play an important role in supplying the global pharma industry with advanced drug delivery solutions made of polymer.”

The investment in the three-digit million Euro range includes a R&D center to further drive rapid prototyping of new polymer syringe solutions, as well as a logistics and an integrated administrative area. The facility will manufacture prefillable syringes made of advanced pharmaceutical-grade polymer used for a range of drugs, including mRNA-based formulations.

Schott’s prefillable polymer syringes are designed to safely store and administer highly viscous drugs, emergency, and intensive care medication, as well as cancer treatments. Most recently, new drug categories have entered the market, such as mRNA-based drugs, which can also be safely stored in prefillable polymer syringes. “We are ready to take the next step with major pharmaceutical companies developing next generation medications. Our validated polymer syringe systems meet the demanding requirements of new drug categories, including ultra-low temperature storage applications needed for mRNA-based applications,” says Mario Haas, vice president for the polymer solutions division of Schott’s pharma business unit.

The drug delivery solutions made of high-end polymer, more precisely cyclic olefin copolymer (COC), are break resistant, feature advanced barrier properties, and are biologically inert. The syringes known under the brand Schott Toppac® are manufactured in a state-of-the-art production environment: All manufacturing steps, from injection molding and quality control to sterile packaging, are automated and digitally connected in a cleanroom setting. Furthermore, the inspection technology makes use of machine learning and artificial intelligence principles, collecting data throughout the manufacturing to optimize process parameters.



Fill out the form below to request more information about Schott Inaugurates Plant for Prefillable Polymer Syringes
Discover Our Content Hub
Access Healthcare Packaging's free educational content library!
Unlock Learning Here
Discover Our Content Hub
Test Your Supply Chain Smarts
Take Healthcare Packaging's supply chain quiz to prove your knowledge!
Take Quiz
Test Your Supply Chain Smarts